Advancing breast cancer and lung cancer screening: Expert perspectives to advance programmes in Singapore.
10.47102/annals-acadmedsg.202567
- Author:
Clive TAN
1
;
Ern Yu TAN
2
;
Geak Poh TAN
3
;
Ravindran KANESVARAN
4
Author Information
1. Department of Epidemiology and Preventive Medicine, Tan Tock Seng Hospital, Singapore.
2. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
3. Respiratory & Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
4. Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
- Publication Type:Review
- Keywords:
Breast cancer;
lung cancer;
preventive medicine;
public health;
screening
- MeSH:
Humans;
Singapore/epidemiology*;
Lung Neoplasms/epidemiology*;
Breast Neoplasms/epidemiology*;
Early Detection of Cancer/methods*;
Female;
Mass Screening/organization & administration*
- From:Annals of the Academy of Medicine, Singapore
2025;54(8):498-504
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTION:The high prevalence and mortality rates of breast cancer and lung cancer in Singapore necessitate robust screening programmes to enable early detection and intervention for improved patient outcomes, yet 2024 uptake and coverage remain suboptimal. This narrative review synthesises expert perspectives from a recent roundtable discussion and proposes strategies to advance breast cancer and lung cancer screening programmes.
METHOD:A 2024 roundtable convened clinical practitioners, health policymakers, researchers and patient advocates discussed current challenges and opportunities for improving cancer screening in Singapore. Perspectives and insights were analysed to identify themes related to existing programme gaps, opportunities for innovation and implementation challenges.
DISCUSSION:Singapore's national breast cancer screening programme has been in place for over 2 decades, yet screening uptake remains suboptimal. A national lung cancer screening programme, in contrast, is still in its early stages of implementation. Regardless, employment of risk stratification approaches that integrate genetic, demographic and lifestyle factors could enhance screening effectiveness by identifying high-risk indivi-duals, while also taking local epidemiological trends into consideration. Integration of digital health technologies, artificial intelligence and behavioural change models can enhance cancer screening uptake and accuracy to overcome barriers such as low awareness, cultural beliefs and socioeconomic factors that contribute to low participation rates.
CONCLUSION:Key recommendations include enhancing public awareness, refining screening guidelines, expanding access and applying innovative technologies. A coordinated effort among stakeholders is crucial to continually assess and enhance screening programmes to narrow the practice-policy gap and ultimately reduce breast cancer and lung cancer burden in Singapore.
